In the News: January 5-11

Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links to related Sg2 resources.

Medicare Now Policing for Antibiotic-Resistant Germs

According a recent article in Kaiser Health News, the federal government now includes the spread of antibiotic-resistant germs in its assessment of hospital penalties for potentially avoidable complications. Each year, approximately 2 million people become infected with antibiotic-resistant bacteria, accounting for 250,000 hospital cases resulting in over 23,000 deaths nationwide. Medicare has identified 2 strains of bacteria in its penalty assessment: methicillin-resistant Staphylococcus aureus and Clostridium difficile. These penalties are a part of a larger agenda to regulate and limit antibiotic overprescription as CMS is preparing to launch new hospital requirements.

For more information on antibiotic-resistant pathogens, check out our Expert Insight on the topic.

Health Affairs: Medicare Advantage Enrollees Use Lower-Intensity Post-Acute Care, Have Better Outcomes

A recent Health Affairs study found that Medicare Advantage patients—across 3 high-volume conditions: lower extremity joint replacement, stroke and heart failure—utilized lower-intensity post-acute care (PAC) services and had “lower probability of hospital readmission and higher rates of return to the community,” compared to traditional Medicare patients discharged from the same hospital. The authors estimate that postdischarge costs could be reduced by 16% per episode for traditional Medicare patients if they received the same treatment as Medicare Advantage patients.

PAC has emerged as a major strategic concern for health systems as value-based care becomes the norm. This resource kit showcases Sg2’s wide range of materials to help clients optimize the post-acute segment of their System of CARE.

Cleveland Clinic Doctors Perform Groundbreaking Stroke Surgery

As part of an ongoing clinical trial, the Cleveland Clinic has conducted what it calls the first stroke recovery procedure involving deep brain stimulation surgery. The research aims to help stroke patients who have remained paralyzed after a stroke, providing them the opportunity to rehabilitate and regain function.

Sg2 closely monitors innovations in stroke treatment and the evolution of stroke care. Watch this recent webinar from Sg2 neuroscience experts Jayme Zage and Kate Zentner to learn more about emerging care delivery models and the potential evolution of stroke center designations.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube